Tax withholding moves 37,898 Elanco (ELAN) CEO shares at $24.88
Rhea-AI Filing Summary
Elanco Animal Health Inc President, CEO and Director Jeffrey N. Simmons reported a tax-withholding disposition of 37,898 shares of common stock on March 3, 2026. The disposition, coded as a payment of tax liability, was priced at $24.88 per share.
After this transaction, Simmons directly held 2,051,898 shares of Elanco common stock. A separate line shows an indirect holding of 167,000 shares held by a revocable trust, reported as indirect beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 37,898 shares
Net Sell
2 txns
Insider
Simmons Jeffrey N
Role
PRESIDENT, CEO AND DIRECTOR
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 37,898 | $24.88 | $943K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,051,898 shares (Direct);
Common Stock — 167,000 shares (Indirect, By Revocable Trust)
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Elanco (ELAN) CEO Jeffrey N. Simmons report?
Jeffrey N. Simmons reported a tax-withholding disposition of Elanco common stock. On March 3, 2026, he disposed of 37,898 shares at $24.88 per share to satisfy tax obligations associated with equity compensation.
What does the tax-withholding code F mean in the Elanco (ELAN) Form 4 filing?
Code F in the Form 4 indicates a payment of exercise price or tax liability by delivering securities. In this case, Elanco CEO Jeffrey N. Simmons used 37,898 shares to satisfy tax obligations rather than selling them in an open-market trade.
What indirect ownership in Elanco (ELAN) does Jeffrey N. Simmons report?
Jeffrey N. Simmons reports indirect ownership of 167,000 Elanco common shares held by a revocable trust. This line is classified as indirect beneficial ownership and reflects holdings separate from his directly owned 2,051,898 shares after the reported transaction.